🔗 Share this article

As the US undertakes unprecedented changes to its vaccine guidelines, an unexpected name appears in a surprising turn: Dr. Tracy Beth Høeg, a US-based sports medicine doctor and public health researcher who rose to prominence by casting doubt on coronavirus vaccines during the global health crisis and has zeroed in on alleged fatalities after COVID-19 immunization in her short tenure at the US Food and Drug Administration (FDA).

Planned Changes to Pediatric Immunization Schedule

Agency leaders had intended to announce sweeping revisions to the pediatric vaccination calendar earlier this month, aligning the US with Denmark’s immunization schedule, it is understood – a major change that would place the US out of step with many the world with no evidence for public health gain. This reveal has been pushed back until the coming year.

Rather than the director of the vaccine center, Tracy Beth Høeg is listed to speak at the gathering. She was recently named temporary leader of the FDA’s CDER, the fifth person to head the center this calendar year.

A Shift at the FDA

Høeg's temporary position could signify a closer partnership between the pharmaceutical and vaccine centers as Høeg and Prasad consolidate power at the regulatory agency – and it points to a renewed priority upon dismantling long-standing immunizations at the FDA.

Høeg has repeatedly called for discontinuing specific childhood vaccine recommendations in the US to become more like Denmark, a society with comprehensive healthcare and a citizenry about the size of the state of Wisconsin.

To date comments, she has persisted in emphasizing on vaccination policy – typically the domain of Prasad, director of the FDA’s vaccine center – instead of pharmaceutical oversight.

Doubts Over Expertise

Høeg has no apparent background in drug development, approval processes or management, which has been customary for past directors of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a key advisor to the FDA chief and CBER since March.

“She appears not to have any of the qualifications” for leading the CDER, stated Jonathan Howard. “She lacks experience running a clinical trial. She lacks experience in running a large organization. She has no expertise in industry regulation.”

Previous heads of CBER would “understand legal statutes and the research of drug development”, commented Janet Woodcock. “Clearly, she lacks the kind of background that prior appointees who led CBER have had.”

The drug center has an enormous workload at the FDA, the former commissioner stated.

“Many people just zeroes in on the new drug program, but the generic drug division authorizes a multitude of generic medications. There is also a biosimilars program, over-the-counter program and other areas, and each of these need to be supervised,” Dr. Woodcock said. “The thing you neglect, that’s the thing that I always told people is going to cause problems.”

Additionally, a major leadership component to the role, which supervises in excess of 5,000 personnel. “It is a huge leadership role, if you execute it properly,” she added.

Official Statement and Contentious Initiatives

When asked about concerns about Dr. Høeg's credentials and whether this appointment indicates greater collaboration among agency officials on vaccines, a spokesperson said that the “inquiries rely on incorrect premises”.

“This background is consistent with the responsibilities of her job,” the official said, noting the time Høeg spent counseling the agency head on “pharmaceutical safety and regulatory science, including computerized risk analysis and immunization monitoring”.

As acting director, Høeg takes over the commissioner’s new fast-track approval initiative, a contentious one-day drug-approval program that reportedly troubled her former heads. “By what process are these therapies being picked for this voucher program? Who makes the choices?” Dr. Howard asked. “There’s a lot of confidentiality occurring at the agency right now.”

In general, he said, “the agency appears to be shifting towards more relaxed rules of most medications, aside from vaccines.”

Established Track Record on Vaccines

Regarding immunizations, Dr. Høeg has a more established, if troubling, track record, Howard observe. She authored a study using unverified crowd-sourced reports to assess the incidence of heart inflammation following COVID-19 vaccination. She counseled the state of Florida top health official Dr. Joseph Ladapo, who was said to have changed statistics to imply COVID-19 vaccinations are more dangerous than they are.

Among her “desired changes” for the current federal leadership featured altering rules for recently developed shots and discontinuing “non-essential” vaccines, she stated after the election on a audio program. At the agency, Dr. Høeg has according to sources proposed preventing adolescent males from obtaining Covid vaccinations.

“She’s an complete ideologue who commences with her beliefs and reverse-engineers to retrofit the science in a highly misleading, untruthful manner,” Howard stated.

Consolidating Power and a “Revenge Tour”

Høeg joined other skeptics, {like|